Predictive genomics: A cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data

TL;DR

This paper introduces a cancer hallmark network framework that models genome sequencing data to predict tumor evolution and clinical outcomes, aiming to improve personalized cancer diagnosis and treatment strategies.

Contribution

The paper presents a novel network framework integrating cancer hallmarks with genome data to predict tumor evolution and clinical phenotypes.

Findings

Framework effectively predicts cancer clonal evolution

Potential to identify personalized drug targets

Assists in cancer risk assessment for healthy individuals

Abstract

We discuss a cancer hallmark network framework for modelling genome-sequencing data to predict cancer clonal evolution and associated clinical phenotypes. Strategies of using this framework in conjunction with genome sequencing data in an attempt to predict personalized drug targets, drug resistance, and metastasis for a cancer patient, as well as cancer risks for a healthy individual are discussed. Accurate prediction of cancer clonal evolution and clinical phenotypes will have substantial impact on timely diagnosis, personalized management and prevention of cancer.